Mushrooms, pizza and more items recalled by the FDA. Here's the list for December 2024
FDA receives reports almost daily from different food companies regarding potential allergens or foodborne illnesses.
Merck to discontinue drug for bacterial infection
Merck will discontinue its drug for a bacterial infection that can lead to fatal diarrhea, the U.S. Food and Drug ...
McKnight's Long-Term Care News8h
FDA updates meaning of ‘healthy’ on food labels
The US Food and Drug Administration wants to redefine the meaning of healthy food, issuing a new rule Thursday that changes ...
FDA approves anti-obesity drug as first sleep apnea medication
The US FDA approved Eli Lilly's Zepbound as the first ever medication for obstructive sleep apnea for patients who also have ...
US FDA approves Hikma's generic version of Novo's diabetes drug Victoza
The U.S. Food and Drug Administration on Monday approved Hikma Pharmaceuticals' generic version of Novo Nordisk's diabetes ...
AstraZeneca withdraws application for lung cancer drug in EU
AstraZeneca has voluntarily withdrawn its marketing authorisation application with the EU's medicines regulator for its ...
Eggs now qualify as ‘healthy’ food, FDA says: Here’s why
While eggs haven’t historically been considered a "health food," the U.S. Food and Drug Administration (FDA) now classifies ...
Everyday Health20h
FDA Says Shortages of GLP-1 Drugs Mounjaro and Zepbound Are Over
Tirzepatide, the active ingredient in both Mounjaro for type 2 diabetes and Zepbound for weight loss, was in short supply for ...
FDA says shortage of GLP-1 drug tirzepatide is over
The U.S. Food and Drug Administration reissued a decision first made by the agency in October that a shortage of the diabetes ...
FDA approves weight-loss drug Zepbound to treat sleep apnea
Zepbound, the new GLP-1 weight-loss drug from Eli Lilly & Co., has been approved by the Food and Drug Administration for ...
Medscape4h
Obesity Drug Zepbound Approved for Obstructive Sleep Apnea
The US Food and Drug Administration approved a new indication for Eli Lilly’s formulation of tirzepatide to treat moderate to ...